Accelovance Announces Opening Offices in China at Maryland Beijing Reception
BEIJING, May 4 /PRNewswire/ -- Accelovance, a Rockville, Maryland based company with a wholly foreign owned enterprise (WFOE) in China held its Accelovance (China) office Grand Opening ribbon cutting ceremony as part of Maryland Beijing Reception last Thursday. This is a key step in the company's strategy to bring a global solution to meeting trial timelines. The Beijing office will serve as the base of operations for clinical sites scheduled to be functioning within 9 months. Sites in China will provide Accelovance's clients with a strategic alternative to their clinical trial needs and will add to the existing 12-site network in the United States. In attendance were 150 guests including representatives from China's Ministry of Foreign Affairs, Ministry of Health, State Food & Drug Administration, Ministry of Science & Technology, Beijing municipal government, as well as representatives from clinical research centers, global pharmaceutical companies and Chinese pharmaceutical industry. This event brought further attention to the continued promotion of the business collaboration between the State of Maryland and China. "We are very excited to be starting our China operations and to be part of the growing collaboration between Maryland and China," commented Accelovance President and CEO, Stephen J. Trevisan. "China brings tremendous value to clinical trial performance. There is a wealth of highly qualified and talented researchers, patients can be enrolled rapidly, and trials can be conducted in a very cost effective manner." Dr. Ken Ren, President of Accelovance China agreed, "We are closer to fulfilling our vision of becoming a global trial management organization. With the growing compliance with international GCP standards, the large number of well-educated and experienced investigators, and huge treatment-naive patient population, China represents one the most attractive areas for conducting global clinical trials for new drug development." Headquartered in Rockville, Maryland, Accelovance is a privately held company that has 12 clinical sites in the United States. In China, the Company will operate through its wholly-owned enterprise in Beijing and establish clinical site networks in the country. Accelovance provides Phase II-IV clinical trial services across a breadth of therapeutic areas that include investigator selection, patient recruitment and study management services for pharmaceutical, contract research organization (CRO), and biotechnology industries. The company is focused on optimizing the quality and productivity of multiple clinical sites, through strong central management and targeted pro-active patient recruitment. Delivering high quality and timely clinical trial support services, Accelovance is committed to understanding and meeting its clients needs to ensure their success. For more information, visit the company's website at http://www.accelovance.com. CONTACT: Media: Garrett D. Smith at 301.222.2212
More by this Source
Sixth Consecutive "Best CRO" Award Nomination for Accelovance
Mar 26, 2013, 10:49 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.